ATE446387T1 - Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie - Google Patents
Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämieInfo
- Publication number
- ATE446387T1 ATE446387T1 AT04782716T AT04782716T ATE446387T1 AT E446387 T1 ATE446387 T1 AT E446387T1 AT 04782716 T AT04782716 T AT 04782716T AT 04782716 T AT04782716 T AT 04782716T AT E446387 T1 ATE446387 T1 AT E446387T1
- Authority
- AT
- Austria
- Prior art keywords
- dot1
- target
- against leukemia
- histone methyltransferases
- therapeutics against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/028289 WO2006025832A1 (en) | 2004-08-31 | 2004-08-31 | Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE446387T1 true ATE446387T1 (de) | 2009-11-15 |
Family
ID=36000364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04782716T ATE446387T1 (de) | 2004-08-31 | 2004-08-31 | Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1791973B1 (de) |
AT (1) | ATE446387T1 (de) |
DE (1) | DE602004023766D1 (de) |
DK (1) | DK1791973T3 (de) |
ES (1) | ES2335411T3 (de) |
WO (1) | WO2006025832A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006336552B2 (en) | 2006-01-20 | 2012-12-20 | The University Of North Carolina At Chapel Hill | Diagnostic and therapeutic targets for leukemia |
AU2013312319B2 (en) | 2012-09-06 | 2018-04-19 | Epizyme, Inc. | Method of treating leukemia |
EP2970135B1 (de) | 2013-03-14 | 2018-07-18 | Epizyme, Inc. | Pyrazolderivate als prmt1 inhibitoren und ihre verwendung |
WO2014153214A1 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Arginine methyl transferase inhibtors and uses thereof |
WO2014153235A2 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
EP2970133B1 (de) | 2013-03-14 | 2018-10-24 | Epizyme, Inc. | Pyrazolderivate als prmt1-inhibitoren und verwendungen davon |
SG11201506972PA (en) | 2013-03-14 | 2015-10-29 | Epizyme Inc | Arginine methyltransferase inhibitors and uses thereof |
US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
EP2970181B1 (de) | 2013-03-14 | 2017-06-07 | Epizyme, Inc. | Argininmethyltransferaseinhibitoren und verwendungen davon |
JP2016518336A (ja) | 2013-03-14 | 2016-06-23 | エピザイム,インコーポレイティド | Prmt1阻害剤としてのピラゾール誘導体およびその使用 |
US20160031839A1 (en) | 2013-03-14 | 2016-02-04 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
US9776972B2 (en) | 2013-03-14 | 2017-10-03 | Epizyme Inc. | Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof |
EP3180348A4 (de) * | 2014-08-08 | 2018-02-07 | Baylor College of Medicine | Dot1l inhibitoren und deren verwendungen |
CN108997480B (zh) * | 2018-07-02 | 2021-07-27 | 中山大学附属第五医院 | 一种具有抑制组蛋白甲基化酶dot1l二甲基化活性的多肽、抑制剂及其设计方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420328A (en) | 1992-09-11 | 1995-05-30 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5525734A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies N.V. | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5817751A (en) | 1994-06-23 | 1998-10-06 | Affymax Technologies N.V. | Method for synthesis of diketopiperazine and diketomorpholine derivatives |
AU2002329784A1 (en) * | 2001-08-17 | 2003-03-03 | Incyte Genomics, Inc. | Molecules for disease detection and treatment |
-
2004
- 2004-08-31 WO PCT/US2004/028289 patent/WO2006025832A1/en active Application Filing
- 2004-08-31 EP EP04782716A patent/EP1791973B1/de not_active Not-in-force
- 2004-08-31 DK DK04782716.7T patent/DK1791973T3/da active
- 2004-08-31 AT AT04782716T patent/ATE446387T1/de not_active IP Right Cessation
- 2004-08-31 DE DE602004023766T patent/DE602004023766D1/de active Active
- 2004-08-31 ES ES04782716T patent/ES2335411T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
WO2006025832A1 (en) | 2006-03-09 |
EP1791973A1 (de) | 2007-06-06 |
EP1791973A4 (de) | 2008-01-23 |
DE602004023766D1 (de) | 2009-12-03 |
ES2335411T3 (es) | 2010-03-26 |
EP1791973B1 (de) | 2009-10-21 |
DK1791973T3 (da) | 2010-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE446387T1 (de) | Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie | |
WO2005073408A3 (en) | Small segments of dna determine animal identity and source | |
ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
ATE553216T1 (de) | Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion | |
ATE548469T1 (de) | Verfahren zur identifizierung mehrerer mutationen oder methylierungsmarkern in einem dominierenden hintergrund von wildtyp-dna | |
ATE468537T1 (de) | Neurodegenerative marker für depression. | |
ATE525482T1 (de) | Nanoreporter und verfahren zu deren herstellung und verwendung | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
CY1111229T1 (el) | Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6 | |
ATE397251T1 (de) | Verfahren für das entwerfen von kleinen erythropoietin mimetika | |
WO2005114218A3 (en) | Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule | |
WO2010033452A3 (en) | Mono-and multi-element coded libs assays and methods | |
ATE504833T1 (de) | Verfahren zur bestimmung des phänotyps von zellen | |
BRPI0607016A2 (pt) | marcadores polipeptìdicos para o diagnóstico de cáncer de próstata | |
MX2007004068A (es) | Placa micro-estampada con micro-tarimas para analisis bioquimico direccionable. | |
WO2005032347A3 (en) | Determining the chemosensitivity of cells to cytotoxic agents | |
ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
ATE414701T1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen | |
WO2007127002A3 (en) | Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors | |
DK1381696T3 (da) | Methods | |
WO2007066129A3 (en) | A method of detecting skeletal muscle damage | |
WO2003071252A3 (en) | Methods for analysis of molecular events | |
DE60327776D1 (de) | Sonden zum nachweis von tumorzellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |